image description

Tag: U.S. Food and Drug Administration

Lupus Awareness Month Celebrated Community with Promise and Hope

May 31, 2024 For centuries writers have described May as a time budding with promise. How apt that it is also when the world recognizes Lupus Awareness Month. With 31 days of May behind us, we celebrate the community that has banded together to make a difference. We appreciate all your amazing contributions throughout the […] Read More

2021 Senate Budget Bill Includes Increases for Medical Research

November 11, 2020 The Lupus Research Alliance is pleased to share details of the 2021 spending package announced by the U.S. Senate last night with several potential “wins” for lupus research. While not 100% in line with our requests, funding for lupus research is substantial and due in large part to the hard work of […] Read More

LRA Writes President Supporting Dr. Janet Woodcock for FDA Commissioner

March 31, 2021 As part of the LRA’s mission to accelerate development and availability of much-needed new diagnostics and treatments for lupus, the organization’s President and CEO, Mr. Kenneth M. Farber, submitted a letter to President Joseph Biden to express LRA’s strong support for Dr. Janet Woodcock to be nominated for Commissioner of the U.S. […] Read More

Three Healthcare Organizations Issue Statement on FDA Action to End Emergency Authorization of Medications to Treat COVID-19

June 24, 2020 Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on new FDA action to Remove Emergency Use Authorization of Medications to Treat COVID-19 The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists issued a statement “emphasizing that the FDA’s recent announcement to cancel the emergency […] Read More

MARCH 26 STATEMENT: Lupus Research Alliance Puts Plaquenil (Hydroxychloroquine) Shortage into Perspective for Lupus Community

March 26, 2020 The Lupus Research Alliance (LRA), the world’s leading research organization dedicated to lupus research, continues to watch rapidly changing developments regarding COVID-19 and is closely monitoring the policies and actions of the federal government, healthcare agencies, medical organizations and the pharmaceutical industry on behalf of people with lupus. Thrust into the spotlight […] Read More
Stay informed about events, research developments, and ways you can help. Sign up for updates